Dean Mid Cap Value holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Dean Mid Cap Value Fund DALCX
- NAV / 1-Day Return $31.35 / +1.13 %
- Fund Size $273.8M
- Adjusted Expense Ratio 0.850%
- Net Expense Ratio 0.850%
- Fee Level: Distribution Below Average
- Share Class Type No Load
- Morningstar Category Mid-Cap Value
- Equity Style Box (Funds) Mid Value
- Minimum Initial Investment $1,000
- Investment Status Open
- TTM Yield 0.85%
- Turnover Ratio 31%
Morningstar’s Analysis DALCX
Will DALCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 23.7
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Jazz Pharmaceuticals PLC | 2.97 | 8M | Healthcare |
Aitc-Bank Deposit | 2.64 | 7M | Cash and Equivalents |
Bank of New York Mellon Corp | 2.61 | 7M | Financial Services |
Arrow Electronics Inc | 2.59 | 7M | Technology |
Encompass Health Corp | 2.37 | 6M | Healthcare |
Ameren Corp | 2.30 | 6M | Utilities |
Cognizant Technology Solutions Corp Class A | 2.28 | 6M | Technology |
Reinsurance Group of America Inc | 2.23 | 6M | Financial Services |
Raymond James Financial Inc | 2.14 | 6M | Financial Services |
OGE Energy Corp | 2.13 | 6M | Utilities |